| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8337408 | The Journal of Nutritional Biochemistry | 2013 | 9 Pages |
Abstract
In conclusion, the identification of a novel broad inhibitory capacity of the natural compound kaempferol for human-derived HDAC enzymes opens up the perspective for clinical application in both tumor prevention and therapy. Moreover, kaempferol may serve as a novel lead structure for chemical optimization of pharmacokinetics, pharmacology or inhibitory activities.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies, Alexander Böcker, Christian Busch, Timo Weiland, Seema Noor, Christian Leischner, Thomas S. Weiss, Ulrich M. Lauer, Stephan C. Bischoff, Michael Bitzer,